Stereotactic Body Radiation Therapy and Aflibercept in Treating Patients With Uveal Melanoma
Clinical trial NCT03712904 · TERMINATED
Trial details
- NCT number
- NCT03712904
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-09
- Primary completion
- 2022-09-20
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.